Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: A secondary analysis of RTOG studies 83-15 and 88-06

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 2, 2000, Pages 299-303

  Corn, Benjamin W ^a   Dolinskas, Carol ^b   Scott, Charles ^c   Donahue, Bernadine ^d   Schultz, Christopher ^e   Nelson, Diana F ^f   Fisher, Barbara ^g  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c RADIATION THERAPY ONCOLOGY GROUP   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f MAYO CLINIC   (United States)

^g LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

CHOD chemotherapy; Imaging response; Primary CNS lymphoma; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LYMPHOMA; MALE; MIDDLE AGED; MULTICENTER STUDIES; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE;

EID: 0034193236     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00470-3     Document Type: Article

References (16)

1. Corn B.W., Marcus S.M., Topham A., Hauck W., Curran W.J. Will primary central nervous system lymphoma be the most frequently diagnosed brain tumor in the year 2000? Cancer. 79:1997;2409-2413.
2. Schultz C., Scott C., Sherman W., Donahue B., Fields J., Murray K., et al. Pre-irradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphoma Initial report of Radiation Therapy Oncology Group protocol 88-06 . J Clin Oncol. 14:1996;556-564.
3. Nelson D.F., Martz K.L., Bonner H.L., Nelson J.S., Newall J., Kerman H.D., et al. Non-Hodgkin's lymphoma of the brain Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG 83-15) . Int J Radiat Oncol Biol Phys. 23:1992;9-17.
4. Murray K., Kun L., Cox J. Primary malignant lymphoma of the central nervous system. J Neurosurg. 65:1986;600-607.
5. Blay L.Y., Bouhour D., Carrie C., Bouffet E., Brunat-Mentigny M., Philip T., et al. The C5R protocol A regimen of high dose chemotherapy and radiotherapy in non-Hodgkin's cerebral lymphoma occurring in immunocompetent patients . Proc Am Soc Oncol. 14:1995;144.
6. Mantel N. Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother Rep. 50:1972;187-220.
7. Cox D.R. Regression models and lifetables. J Royal Stat Soc. 30:1972;187-220.
8. Dahlborg S.A., Henner W.D., Crossen J.R., Tableman M., Petrillo A., Braziel R., et al. Non-AIDS primary CNS lymphoma First example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy . Can J Sci Am. 2:1996;166-174.
9. Corn B.W., Donahue B.R., Rosenstock J.G., Hyslop T., Brandon A.H., Hedgde H.H., et al. Performance status and age as independent predictors of survival among AIDS patients with primary central nervous system lymphoma A multivariate analysis of a multi-institutional experience . Cancer J Sci Am. 2:1997;52-56.
10. Corn B.W., Trock B.D., Curran W.J. Management of primary central nervous system lymphoma for the patient with the acquired immunodeficiency syndrome Confronting a clinical catch-22 . Cancer. 76:1995;163-166.
11. DeAngelis L.M., Yahalom J., Thaler H.T., Kher U. Combined modality therapy for primary central nervous system lymphoma. J Clin Oncol. 10:1992;635-643.
12. O'Neill B.P., Wang C.H., O'Fallon J.R. Primary central nervous system lymphoma (PCNSL) Survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) study 86-72-52 . Int J Radiat Oncol Biol Phys. 43:1999;559-563.
13. Remick S.C., Diamond C.D., Migliozzi J.A., et al. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome A retrospective analysis and review of the literature . Medicine. 69:1990;345-360.
14. Goffman T.E., Glatstein E. Central nervous system lymphoma Back to the drawing board . Int J Radiat Oncol Biol Phys. 23:1992;247-248.
15. Glass J., Gruber M., Cher L., Hochberg F.H. Pre-irradiation methotrexate chemotherapy of primary central nervous lymphoma Long term outcome . J Neurosurg. 81:1994;188-195.
16. Hji Yiannakis P., Traish D., Hines F., Ashley S., Brada M. Phase II study of combined modality therapy in primary CNS lymphoma. Br J Cancer. 27:1995;21.